Background: GDM is defined as carbohydrate intolerance of variable severity with onset or first recognition during pregnancy. Women with gestational diabetes are characterized by a relatively diminished insulin secretion and pregnancy induced insulin resistance primarily present in the skeletal muscle tissue. Normal pregnancy is a diabetogenic state characterized by exaggerated rate and amount of insulin release, associated with decreased sensitivity to insulin at cellular levels. The objective of the study was to study the maternal, the fetal and the neonatal outcomes of treated patients of GDM in present study. Methods: It was a hospital based clinical study. 1000 patients were enrolled between 24-28 weeks of gestation and DIPSI test was performed. Diagnosis of GDM was done using DIPSI criteria. 80 patients were diagnosed with GDM and followed till delivery to study the maternal, fetal and neonatal outcome. Results: Elderly patients, patients with previous history of GDM, patients with family history of diabetes, patients with high BMI and patients with polyhydramnios are at high risk for GDM. Conclusions: Hypertensive disorders and preterm birth are known to be higher with GDM are similar to the non-GDM group suggesting that early diagnosis and prompt treatment and maintaining strict glycemic control by patient may be beneficial. GDM can be managed well on MNT and lifestyle modifications, only few patients required insulin therapy. In spite of appropriate glycemic control, the incidence of macrosomia found to be high in GDM group. Sudden unexplained stillbirth can occur in spite of strict glycemic control. Neonatal complications have occurred despite well glycemic control.
INTRODUCTION
Diabetes mellitus is a group of metabolic disorders characterized by hyperglycemia resulting from defects in insulin secretion, insulin action or both. 1 It is defined as carbohydrate intolerance of variable severity with an onset or first recognition during pregnancy. 2 Women with gestational diabetes are characterized by a relatively diminished insulin secretion and pregnancy induced insulin resistance primarily present in the skeletal muscle tissue. Normal pregnancy is a diabetogenic state characterized by exaggerated rate and amount of insulin release, associated with decreased sensitivity to insulin at cellular levels. Many of the changes are results of the progressive rise in the levels of estrogen, progesterone, human placental lactogen, cortisol and prolactin as pregnancy advances. Many of these hormones are insulin antagonists, causing insulin resistance in the mother and cause abnormal glucose tolerance in some women rendering them to develop gestational diabetes. 3 During early pregnancy, glucose crosses the placenta to the fetus by facilitated diffusion resulting in the decrease in fasting blood glucose to 50-65 mg%. As pregnancy progresses 3 factors are responsible for causing post prandial hyperglycemia: insulin antagonists such as estrogen, progesterone and human placental lactogen. There is 3fold rise in serum cortisol and human placenta contains enzymes (eg. insulinase) that increase the degradations by potentiating the secretion of insulin, but in GDM the pancrease fail to respond adequately. 4 GDM is associated with increased fetomaternal morbidity as well as long term complications in mother and babies. American college of obstetricians and gynecologists (ACOG) on contrary advocates selective screening for patients with high risk factors such as history of previous GDM, strong family history of diabetes, member of an ethnic group with high prevalence of GDM, maternal age more than 25 years, obesity, persistent glycosuria, macrosomia (birth weight >4gm,)polycystic ovarian syndrome, spontaneous abortions and unexplained still births. 5 Maternal complications are increased incidence of asymptomatic bacteriuria, urinary tract infections, increased incidence of pre ecclamsia,10% risk of polyhydramnios which may increase the incidence of preterm labour, placental abruption and postpartum hemorrhage. Risk of developing diabetes mellitus and the complications in fetus are macrosomia, which will increase risk of operative delivery and shoulder dystocia, increase incidence of hypoglycemia, hypocalcemia, congenital malformations, polycythemia, hyperbilirubinemia, respiratory distress syndrome, and long term complications are obesity, development of type 2 diabetes mellitus during childhood, impaired motor functions and higher rates of in attention and hyper activity. 6 Several studies have shown that 50% GDM developed diabetes mellitus within 10-20 years of index pregnancy. Furthermore, there were reported increased incidence of hypertension, hyperlipedimia, proteinuria, abnormal ECG and higher morbidity and mortality.
The incidence of juvenile diabetes mellitus in offspring is 20 times more than in the controlled population. Attempts to detect unrecognized diabetes in pregnancy should be practiced in antenatal clinics which are justified by the increased risk of maternal, perinatal and neonatal morbidity mortality among women with abnormal OGTT in pregnancy.
METHODS
It was a hospital based study. 1000 pregnant women in second trimester between 24-28 weeks of gestational age attending antenatal clinic of tertiary care center in a time period of one year (September 2015 to December 2016) were enrolled in this study after providing informed consent. Diagnosis of GDM was done using DIPSI criteria. A detailed assessment of patient was performed including history (any family history of diabetes, history of previous pregnancies and socioeconomic status etc.), general examination and obstetric examination. Routine investigations during antenatal visits were done. Informed consent to participation was taken during initial assessment. A standard proforma was used to record the data of tests performed, detailed clinical assessment of patients, including history and examination findings, investigations including the test results.
Diabetes in Pregnancy Study Group India (DIPSI) diagnostic criterion of 2-h plasma glucose ≥7.8 mmol/L with 75 gm oral glucose load is a modified version of WHO criterion, in that the WHO procedure requires women to be in the fasting state, whereas DIPSI procedure was performed in the fasting/ non-fasting state irrespective of last meal timing. Diagnosis of GDM according to DIPSI criteria is as follows. 7
Inclusion criteria
• All consenting pregnant women in second trimester between 24-28 weeks • Pregnant women of any parity • Singleton pregnancy.
Exclusion criteria
• Pre-gestational diabetes • Chronic renal/ cardiac/ hepatic/ respiratory diseases • Taking drugs that alter glucose metabolism • Women who refuse to participate. 
RESULTS
Out of the 1000 women screened 80 women were diagnosed as GDM using DIPSI criteria. Maternal, fetal and neonatal outcomes compared in women with GDM and those without GDM. Table 3 chisquare value is 69.44, df is 2 and P value is <0.0001. Which signifies positive co-relation of high body mass index with incidence of gestational diabetes mellitus. From Table 4 the incidence of GDM in primigravida was 6 (7.5%) and in multigravida it was 74 (92.5%). For Table 4 Pearson's chi-square value is 5.74, df is 1 and P value is 0.016, which implies positive co-relation between multigravida and GDM. Table 5 shows that there were total 27 patients with previous history of GDM of which 18 (22.5%) developed GDM in this pregnancy and only 9 (0.98%) were non GDM.
Out of 973 patients with no previous history of GDM only 62 (77.50%) developed GDM and 911 (99.02%) were non GDM. For Table 5 Pearson's chi-square value is 121.7, df is 1 and P value is <0.0001. Which signifies positive co-relation between previous history of GDM and GDM. For Table 6 Pearson's chi-square value is 82.27, df is 1 and P value is <0.0001. Which shows strong association between family history of diabetes and GDM. From Table 8 , incidence of pre-eclampsia was almost same in gestational diabetes mellitus (11.25%) and nongestational diabetes mellitus group (10.87%). For Table 8 Pearson's chi-square value is 0.01, df is 1 and P value is 0.92. Which is statistically non-significant and implies there is no co-relation between gestational diabetes mellitus and occurrence of pre-eclampsia. For study purpose, we have defined polyhydramnios as amniotic fluid index (AFI) more than 20 cm and oligohydramnios as amniotic fluid index less than 5 cm. From Table 9 , in patients with gestational diabetes mellitus polyhydramnios was found in 6 (7.5%) cases and normal AFI in 74 (92.5%) cases. Whereas in nongestational diabetes mellitus group polyhydramnios was found in 16 (1.74%) cases, oligohydramnios in 3 (0.33%) cases and normal AFI in 901 (97.94%) cases. For Table 9 chi-square value is 11.59, df is 2 and P value is 0.003 which suggests association of polyhydramnios with gestational diabetes mellitus. Table 10 Pearson's chi-square value is 0.29, df is 1 and P value is 0.59. Which is statistically non-significant and implies there is no co-relation between gestational diabetes mellitus and congenital anomalies.
From Table 11 , incidence of macrosomia in gestational diabetes mellitus was 42.50% whereas it was quite low for non-gestational diabetes mellitus i.e. 8.70%. Whereas normal and low weight babies were relatively higher in non-gestational diabetes mellitus cases (80% and 11.30% respectively) than in case of gestational diabetes mellitus cases (52.50% and 5% respectively). For Table 11 chi-square value is 83.64, df is 2 and P value is <0.0001 which suggests there is strong corelation between macrosomia and gestational diabetes mellitus. For Table 13 Pearson's chi-square value is 0.02, df is 1 and P value is 0.8875. Which is statistically nonsignificant and implies there no is co-relation between gestational diabetes mellitus and gestational age at delivery. From Table 14 , incidences of caesarean, instrumental and normal deliveries in patients with gestational diabetes mellitus cases were 23.75%, 3.75% and 72.50 % respectively whereas in non-gestational diabetes mellitus cases it stood for 26.85%, 2.61% and 70.54% respectively, which were approximately equal in both GDM and non-GDM cases. For Table 14 chi-square value is 0.66, df is 2 and P value is 0.7189 which suggests there is no co-relation of type of delivery with gestational diabetes mellitus.
Neonatal complications like hyperbilirubinemia (12.5%), hypoglycemia (10%), RDS (5%), still birth (2.5%) and sepsis (3.75%) (table 22) in gestational diabetes mellitus were collectively 33.75% whereas they stood at 4.78% (Table 15 ) for non-gestational diabetes mellitus group. For Table 16 Pearson's chi-square value is 89.29, df is 1 and P value is <0.0001 which implies very strong corelation of gestational diabetes mellitus with incidence of neonatal complications. 
DISCUSSION

Risk factors for GDM
Compared with women of normal OGTT, women with GDM were older. The mean age in GDM group was 26.625±4.309 years while in non-GDM group it was 25.269±3.505 years. Similar study from south India showed age more than 25 years as a risk factor for GDM. 8 Several studies revealed that obesity is significant risk factor for GDM. Obesity or overweight at the start of pregnancy predisposes to GDM. In present study, we had 64.29% obese (BMI>30kg/m 2 ) cases were having GDM, which was 67% (BMI>25kg/m 2 ) in study done by Kalra In present study 92.5% cases of GDM were multigravida (gravida 2 and above), whereas in study done by Rajput M. et al it was 18.2%, while in study done by Seshiah et al it was 25.8%, these both studies considered multigravida as gravida 4 and above. 11, 12 It suggests significant correlation between multigravidity and GDM.
In current study, there were 22.5% cases of GDM having previous history of GDM, while in study done by Seshiah et al about 50% patients were having previous history of GDM. 13 In this study, there were 42.5% cases of GDM having family history of diabetes in first degree relatives, while in study done by Bhat M. et al it was 37.3%. 14 15, 8, 16, 11 Thus, family history of diabetes is significant risk factor associated with development of GDM.
Incidence of obstetric complications in GDM cases
In this study hypertensive disorders in pregnancy like pre-eclampsia was found in 9 (11.25%) cases, PROM in 1 ( There were 10 (12.5%) babies of neonatal hyperbilirubinemia in our study, while there were 6 (10.12%) babies in study done by Priyanka Kalra, et al.
There was no case of shoulder dystocia in our present study as was seen in 7 (10%) cases in study done by Kalra P et al. and 1(3%) case in study done by Wahi P, et al.
CONCLUSION
Study found that elderly patients, patients with previous history of GDM, patients with family history of diabetes, patients with high BMI and patients with polyhydramnios are at high risk for GDM. In study, obstetric complications like hypertensive disorders and preterm birth are known to be higher with GDM are similar to the non-GDM group suggesting that early diagnosis and prompt treatment and maintaining strict glycemic control by participant may be beneficial. GDM can be managed well on MNT and lifestyle modifications, only few patients required insulin therapy. In spite of appropriate glycemic control, the incidence of macrosomia is found to be high in GDM group. Sudden unexplained stillbirth can occur in spite of strict glycemic control. Neonatal
